Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Sep 28, 2009; 15(36): 4561-4565
Published online Sep 28, 2009. doi: 10.3748/wjg.15.4561
Published online Sep 28, 2009. doi: 10.3748/wjg.15.4561
Table 3 COX-2 haplotypes in patients with CRC and controls
| Haplotype | Patients with CRC (n = 326) | Controls (n = 369) | OR (95% CI) |
| AC/AC | 9 (2.8%) | 8 (2.2%) | 1.16 (0.40-3.42) |
| AG/AC | 59 (18.1%) | 74 (20.1%) | 0.83 (0.54-1.27) |
| AG/AG | 145 (44.5%) | 150 (40.7%) | Reference |
| GC/AC | 1 (0.3%) | - | - |
| GG/AC | 16 (4.9%) | 38 (10.3%) | 0.44 (0.22-0.85) |
| GG/AG | 84 (25.8%) | 86 (23.3%) | 1.01 (0.68-1.50) |
| GG/GG | 12 (3.7%) | 13 (3.5%) | 0.92 (0.38-2.24) |
-
Citation: Hoff JH, Morsche RHT, Roelofs HM, Logt EMVD, Nagengast FM, Peters WH. COX-2 polymorphisms
-765G→C and-1195A→G and colorectal cancer risk. World J Gastroenterol 2009; 15(36): 4561-4565 - URL: https://www.wjgnet.com/1007-9327/full/v15/i36/4561.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.4561